The effects of catechol-O-methyltransferase inhibition on estrogen metabolite and oxidative DNA damage levels in estradiol-treated MCF-7 cells
- PMID: 11606384
The effects of catechol-O-methyltransferase inhibition on estrogen metabolite and oxidative DNA damage levels in estradiol-treated MCF-7 cells
Abstract
Many of the major identified risk factors for breast cancer are associated with exposure to endogenous estrogen. In addition to the effects of estrogen as a growth factor, experimental and epidemiological evidence suggest that catechol metabolites of estrogen also contribute to estrogen carcinogenesis by both direct and indirect genotoxic mechanisms. O-Methylation catalyzed by catechol-O-methyltransferase (COMT) is a Phase II metabolic inactivation pathway for catechol estrogens. We and others have found that a polymorphism in the COMT gene, which codes for a low activity variant of the COMT enzyme, is associated with an increased risk of developing breast cancer; therefore, the goal of the current study was to investigate the role of decreased COMT activity on estrogen catechol levels and on oxidative DNA damage, as measured by 8-hydroxy-2'-deoxyguanosine (8-oxo-dG) levels. MCF-7 cells were pretreated with dioxin as a means to increase estrogen metabolism to catechol estrogens, then treated with estradiol (E2) +/- Ro 41-0960, a COMT-specific inhibitor. After extraction from culture medium, estrogen metabolites were separated using an high-performance liquid chromatography-electrochemical detection method. As expected, dioxin dramatically increased E2 oxidative metabolism, primarily to its 2-OH and 2-methoxy metabolites. The COMT inhibitor blocked 2-methoxy E2 formation. This was associated with increased 2-hydroxy E2 (2-OH E2) and 8-oxo-dG levels. In the presence of COMT inhibition, increased oxidative DNA damage was detected in MCF-7 cells exposed to as low as 0.1 microM E2, whereas in the absence of COMT inhibition, no increase in 8-oxo-dG was detected at E2 concentrations < or =10 microM. This study is the first to show that O-methylation of 2-OH E2 by COMT is protective against oxidative DNA damage caused by 2-OH E2, a major oxidative metabolite of E2.
Similar articles
-
Catechol-O-methyltransferase (COMT)-mediated metabolism of catechol estrogens: comparison of wild-type and variant COMT isoforms.Cancer Res. 2001 Sep 15;61(18):6716-22. Cancer Res. 2001. PMID: 11559542
-
Phytochemicals inhibit catechol-O-methyltransferase activity in cytosolic fractions from healthy human mammary tissues: implications for catechol estrogen-induced DNA damage.Toxicol Sci. 2004 Oct;81(2):316-24. doi: 10.1093/toxsci/kfh216. Epub 2004 Jul 14. Toxicol Sci. 2004. PMID: 15254334
-
17 beta-estradiol metabolism by hamster hepatic microsomes: comparison of catechol estrogen O-methylation with catechol estrogen oxidation and glutathione conjugation.Chem Res Toxicol. 1996 Jun;9(4):793-9. doi: 10.1021/tx9501952. Chem Res Toxicol. 1996. PMID: 8831825
-
Mechanisms of estrogen carcinogenesis: The role of E2/E1-quinone metabolites suggests new approaches to preventive intervention--A review.Steroids. 2015 Jul;99(Pt A):56-60. doi: 10.1016/j.steroids.2014.08.006. Epub 2014 Aug 24. Steroids. 2015. PMID: 25159108 Free PMC article. Review.
-
Estrogen mediation of breast tumor formation involves estrogen receptor-dependent, as well as independent, genotoxic effects.Ann N Y Acad Sci. 2009 Feb;1155:132-40. doi: 10.1111/j.1749-6632.2008.03685.x. Ann N Y Acad Sci. 2009. PMID: 19250200 Review.
Cited by
-
Reduced formation of depurinating estrogen-DNA adducts by sulforaphane or KEAP1 disruption in human mammary epithelial MCF-10A cells.Carcinogenesis. 2013 Nov;34(11):2587-92. doi: 10.1093/carcin/bgt246. Epub 2013 Jul 10. Carcinogenesis. 2013. PMID: 23843041 Free PMC article.
-
Contributions of human enzymes in carcinogen metabolism.Chem Res Toxicol. 2012 Jul 16;25(7):1316-83. doi: 10.1021/tx300132k. Epub 2012 May 10. Chem Res Toxicol. 2012. PMID: 22531028 Free PMC article. Review.
-
Is there a role for base excision repair in estrogen/estrogen receptor-driven breast cancers?Antioxid Redox Signal. 2014 Dec 1;21(16):2262-8. doi: 10.1089/ars.2014.6077. Epub 2014 Sep 22. Antioxid Redox Signal. 2014. PMID: 25111287 Free PMC article.
-
Estrogens and the risk of breast cancer: A narrative review of literature.Heliyon. 2023 Sep 17;9(9):e20224. doi: 10.1016/j.heliyon.2023.e20224. eCollection 2023 Sep. Heliyon. 2023. PMID: 37809638 Free PMC article. Review.
-
Estrogen metabolism and breast cancer.Cancer Lett. 2015 Jan 28;356(2 Pt A):231-43. doi: 10.1016/j.canlet.2014.04.018. Epub 2014 Apr 28. Cancer Lett. 2015. PMID: 24784887 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical
Research Materials
Miscellaneous